Kenneth Bate Epizyme, Inc. (EPZM) insider trading activity

EPZM Quotes by TradingView

Kenneth Bate is Director of Epizyme, Inc.. Currently has a direct ownership of 0 shares of EPZM, which is worth approximately $0. The most recent transaction as insider was on Aug 12, 2022, when has been sold 17,054 shares (Common Stock, par value $0.0001) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0
0% 3M change
0% 12M change
Total Value Held $0

KENNETH BATE Transaction History

Date Transaction Value Shares Traded Shares Held Form
Aug 12 2022
SELL
Sale (or disposition) back to the issuer
-
17,054 Reduced 100.0%
0 Common Stock, par valu...
May 17 2022
BUY
Grant, award, or other acquisition
-
8,994 Added 34.53%
17,054 Common Stock, par valu...
Jun 11 2021
BUY
Grant, award, or other acquisition
-
8,060 Added 50.0%
8,060 Common Stock, par valu...

Also insider at

ATXS
Astria Therapeutics, Inc. Healthcare
Director
AVEO
AVEO PHARMACEUTICALS, INC. Healthcare
Director
MDGL
MADRIGAL PHARMACEUTICALS, INC. Healthcare
GNCA
GENOCEA BIOSCIENCES, INC. Healthcare
Director
KB

Kenneth Bate

Director
Cambridge, MA

Track Institutional and Insider Activities on EPZM

Follow Epizyme, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells EPZM shares.

Notify only if

Insider Trading

Get notified when an Epizyme, Inc. insider buys or sells EPZM shares.

Notify only if

News

Receive news related to Epizyme, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on EPZM